What the phase 1 trials of the first COVID-19 vaccine really mean
Early morning on May 18, Moderna, a biotechnology company, revealed the preliminary findings for the much anticipated phase I trial of an mRNA COVID-19 vaccine. The information sent Moderna’s stock soaring by more than 20% and helped fuel a rally on Wall Street. Although there was an enthusiastic response to the news, the purpose of […]